Stay updated with breaking news from Katja Arnold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: QUANTRO Therapeutics GmbH / Key word(s): Miscellaneous QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class
EQS-News: QUANTRO Therapeutics GmbH / Key word(s): MiscellaneousQUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments 04.06.2024 / 23:07 CET/CESTThe issuer is solely responsible for the content of this announcement.QUANTRO Therapeutics rea...
JENA, Germany, May 21, 2024 -- InflaRx N.V. , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American...
InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization but do not survive. InflaRx is determined to support broader access to GOHIBIC for eligible...
MAD pharmacokinetic and pharmacodynamic data support best-in-class potential of INF904 over tested dose range of 30 mg once per day (QD) to 90 mg ...